Mycestericin E

Drug Profile

Mycestericin E

Alternative Names: 4-deoxymyriocin; 6,7-dehydromycestericin G

Latest Information Update: 21 Jul 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Developer Nonindustrial source; Taito
  • Class Small molecules
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Immunological disorders

Most Recent Events

  • 21 Jul 1998 No-Development-Reported for Immunological disorders in Japan (Unknown route)
  • 01 Dec 1995 Preclinical development for Immunological disorders in Japan (Unknown route)
  • 01 Nov 1995 This profile is new.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top